L2: Update COMM
Quiénes somos
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors
Phase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in Patients With Advanced Cancer
Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC
Estudio de cánceres gastrointestinales metastásicos tratados con linfocitos infiltrantes tumorales en los que se inhibe el gen que codifica el punto de control inmunitario intracelular CISH mediante ingeniería genética CRISPR.
Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
Estudio de células CAR-T mediadas por CRISPR-Cas9 con genes PD-1 y TCR knocked out dirigidos a mesotelina en pacientes con tumores sólidos múltiples mesotelina positivos.
Estudio de fase I/II de células T autólogas que expresan receptores de células T (TCR) en sujetos con tumores sólidos
Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer
